Voluntary Recall of Certain Lots of Haemophilus Influenza Type b (Hib) Vaccine Produced by Merck & Co., Inc.

Merck & Co. announced that it has initiated a voluntary recall in the United States for certain lots of PedvaxHIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] and COMVAX® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine]. CDC understands that this recall will present several challenges to public health and provider partners. They are working rapidly to gather and assess information which will allow them to develop guidance for immunization providers and their patients.
For additional information please click on http://www.cdc.gov/vaccines/recs/recalls/hib-recall-faqs-12-12-07.htm